Works matching Feminizing hormone therapy


Results: 62
    1
    2
    3

    Feminizing hormone therapy in a Canadian cohort of transgender women with and without HIV.

    Published in:
    Antiviral Therapy, 2023, v. 28, n. 3, p. 1, doi. 10.1177/13596535231182505
    By:
    • Armstrong, Ian;
    • Lacombe-Duncan, Ashley;
    • Shokoohi, Mostafa;
    • Persad, Yasmeen;
    • Tseng, Alice;
    • Fung, Raymond;
    • Underhill, Angela;
    • Côté, Pierre;
    • Machouf, Nimâ;
    • Saucier, Adrien;
    • Varriano, Brenda;
    • Brundage, Monica;
    • Jones, Reilly;
    • Weisdorf, Thea;
    • Goodhew, John;
    • MacLeod, John;
    • Loutfy, Mona
    Publication type:
    Article
    4

    Impact of feminizing hormone therapy on tenofovir and emtricitabine plasma pharmacokinetics: a nested drug-drug interaction study in a cohort of Brazilian transgender women using HIV pre-exposure prophylaxis.

    Published in:
    2022
    By:
    • Cattani, Vitória Berg;
    • Jalil, Emilia Moreira;
    • Eksterman, Leonardo;
    • Torres, Thiago;
    • Cardoso, Sandra Wagner;
    • Castro, Cristiane R V;
    • Monteiro, Laylla;
    • Wilson, Erin;
    • Bushman, Lane;
    • Anderson, Peter;
    • Veloso, Valdilea Gonçalves;
    • Grinsztejn, Beatriz;
    • Estrela, Rita;
    • team, PrEParadas study;
    • PrEParadas study team
    Publication type:
    journal article
    5
    6
    7

    Addition of progesterone to feminizing gender-affirming hormone therapy in transgender individuals for breast development: a randomized controlled trial.

    Published in:
    BMC Pharmacology & Toxicology, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s40360-023-00724-4
    By:
    • Dijkman, Benthe A.M.;
    • Helder, Danithsia;
    • Boogers, Lidewij S.;
    • Gieles, Noor C.;
    • van Heesewijk, Jason O.;
    • Slaa, Sjoerd te;
    • Liberton, Niels P.T.J.;
    • Wiepjes, Chantal M.;
    • de Blok, Christel J.M.;
    • den Heijer, Martin;
    • Dreijerink, Koen M.A.
    Publication type:
    Article
    8

    Drug-drug Interactions Among Thai Transgender Women Living with Human Immunodeficiency Undergoing Feminizing Hormone Therapy and Antiretroviral Therapy: The iFACT Study.

    Published in:
    Clinical Infectious Diseases, 2021, v. 72, n. 3, p. 396, doi. 10.1093/cid/ciaa038
    By:
    • Hiransuthikul, Akarin;
    • Himmad, Linrada;
    • Kerr, Stephen J;
    • Janamnuaysook, Rena;
    • Dalodom, Theera;
    • Phanjaroen, Kannapat;
    • Pankam, Tippawan;
    • Kongkapan, Jiratchaya;
    • Mills, Stephen;
    • Vannakit, Ravipa;
    • Phanuphak, Praphan;
    • Phanuphak, Nittaya
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21

    Decreased Tenofovir Diphosphate Concentrations in a Transgender Female Cohort: Implications for Human Immunodeficiency Virus Preexposure Prophylaxis.

    Published in:
    Clinical Infectious Diseases, 2019, v. 69, n. 12, p. 2201, doi. 10.1093/cid/ciz290
    By:
    • Cottrell, Mackenzie L;
    • Prince, Heather M A;
    • Schauer, Amanda P;
    • Sykes, Craig;
    • Maffuid, Kaitlyn;
    • Poliseno, Amanda;
    • Chun, Tae-Wook;
    • Huiting, Erin;
    • Stanczyk, Frank Z;
    • Peery, Anne F;
    • Dellon, Evan S;
    • Adams, Jessica L;
    • Gay, Cindy;
    • Kashuba, Angela D M
    Publication type:
    Article
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33

    Oestradiol concentrations in trans women with HIV suppressed on unboosted integrase inhibitor regimens versus trans women without HIV taking oral oestradiol: a pilot study.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 11, p. 2653, doi. 10.1093/jac/dkad270
    By:
    • Loutfy, Mona;
    • Lacombe-Duncan, Ashley;
    • Tseng, Alice;
    • Persad, Yasmeen;
    • Underhill, Angela;
    • Kennedy, V Logan;
    • Armstrong, Ian;
    • Fung, Raymond;
    • Bourns, Amy;
    • Nguyen, Quang;
    • Hranilovic, Sue;
    • Weisdorf, Thea;
    • Chan, L Y L;
    • Kia, Hannah;
    • Halpenny, Roberta;
    • Iyer, Harshita;
    • Jeyarajah, Nirubini;
    • Kovchazov, George;
    • McCully, Jennifer;
    • Scarsi, Kimberly K
    Publication type:
    Article
    34
    35
    36

    Correction.

    Published in:
    2025
    Publication type:
    Correction Notice
    37
    38
    39
    40

    Low PrEP adherence despite high retention among transgender women in Brazil: the PrEParadas study.

    Published in:
    Journal of the International AIDS Society, 2022, v. 25, n. 3, p. 1, doi. 10.1002/jia2.25896
    By:
    • Jalil, Emilia M.;
    • Torres, Thiago S.;
    • Luz, Paula M.;
    • Monteiro, Laylla;
    • Moreira, Ronaldo I.;
    • de Castro, Cristiane R. V.;
    • Leite, Iuri da C.;
    • Cunha, Marcello;
    • de Cássia Elias Estrela, Rita;
    • Ramos, Michelle;
    • Hoagland, Brenda;
    • Wagner Cardoso, Sandra;
    • Anderson, Peter;
    • Veloso, Valdilea G.;
    • Wilson, Erin;
    • Grinsztejn, Beatriz
    Publication type:
    Article
    41
    42
    43
    44

    Protocol of a drug–drug interaction study between bictegravir/emtricitabine/tenofovir alafenamide and feminizing hormones in trans women living with HIV.

    Published in:
    British Journal of Clinical Pharmacology, 2024, v. 90, n. 10, p. 2349, doi. 10.1111/bcp.16162
    By:
    • Lacombe‐Duncan, Ashley;
    • Tseng, Alice;
    • Scarsi, Kimberly K.;
    • Senneker, Tessa;
    • Kluger, Hadas;
    • Persad, Yasmeen;
    • Underhill, Angela;
    • Kennedy, V. Logan;
    • Armstrong, Ian;
    • Fung, Raymond;
    • Bourns, Amy;
    • Nguyen, Quang;
    • Hranilovic, Susan;
    • Weisdorf, Thea;
    • Chan, Louie;
    • Kia, Hannah;
    • Halpenny, Roberta;
    • Iyer, Harshita;
    • Jeyarajah, Nirubini;
    • Kovchazov, George
    Publication type:
    Article
    45
    46
    47
    48
    49
    50